Publications

Peer-Reviewed Journal Publications

  1. Zidan A, ElGeed H, Alsalemi N, Hamad A, Ibrahim R, Stewart D, Awaisu A. Deprescribing tools and guidelines in chronic kidney disease: A scoping review. Res Social Adm Pharm. 2025 Sep;21(9):679-686. doi: 10.1016/j.sapharm.2025.05.005. Epub 2025 May 9. PMID: 40368718.
  2. Abdelkader NN, Awaisu A, Elewa H, Mahfoud Z, Al Abdulla SA, Owais A, El Hajj MS. Prescribing trends and patterns for antihypertensive agents in primary healthcare settings in Qatar: a retrospective observational study. J Pharm Policy Pract. 2025 Jun 18;18(1):2512183. doi: 10.1080/20523211.2025.2512183. PMID: 40547565; PMCID: PMC12180352.
  3. Jaam M, Awaisu A, Stewart D, Mukhalalati B, Sethi A, Elshazly M, Abdelrahman A, Hadi MA. Protocol for developing a Consolidated Checklist for Reporting Mixed Methods Research (CORMIX) using modified Delphi. PLoS One. 2025 May 6;20(5):e0321587. doi: 10.1371/journal.pone.0321587. PMID: 40327703; PMCID: PMC12054909.
  4. Zoukh I, Dabbous Z, Owusu Y, Awaisu A. Therapeutic Inertia Quantification in Diabetes Care: A Narrative Review and Synthesis. Clin Ther. 2025 May;47(5):384-389. doi: 10.1016/j.clinthera.2025.02.003. Epub 2025 Mar 12. PMID: 40082100.
  5. Abdelkader N, Awaisu A, Elewa H, Al Abdulla SA, El Hajj MS. Primary care physicians’ perceptions of hypertension management in Qatar: A qualitative study using the theoretical domains framework. PLoS One. 2025 Apr 24;20(4):e0318527. doi: 10.1371/journal.pone.0318527. PMID: 40273161; PMCID: PMC12021218.
  6. Elshami S, Yakti O, Mohamed Ibrahim MI, Awaisu A, Sherbash M, Mukhalalati B. Instruments for the assessment of disaster management among healthcare professionals: a scoping review. Front Public Health. 2025 Apr 11;13:1540743. doi: 10.3389/fpubh.2025.1540743. PMID: 40290498; PMCID: PMC12021930.
  7. Zaghloul N, Awaisu A, Mahfouz A, Ali Z, Alyafei S, Elewa H. Evaluating the appropriateness and the factors associated with sodium-glucose co-transporter 2 inhibitors prescribing in a Middle Eastern country: a cross-sectional study. Int J Clin Pharm. 2025 Apr;47(2):314-324. doi: 10.1007/s11096-024-01828-5. Epub 2024 Nov 21. PMID: 39570571; PMCID: PMC11919983.
  8. Hamad AI, Zidan AZ, Elshirbeny MF, Al-Ali FS, Ghonimi TA, Abdelhadi MY, Filali M, Awaisu A, Ibrahim RA, Alkadi MM, Al-Malki HA. Exploring Mortality and Associated Risks Among Assisted Home Hemodialysis Patients in Qatar. Hemodial Int. 2025 Mar 28. doi: 10.1111/hdi.13236. Epub ahead of print. PMID: 40151953.
  9. Zoukh I, Tabet M, Awaisu A. Scientometric analysis of research productivity in clinical pharmacy and practice: a 12-year review at a Middle Eastern university. J Pharm Policy Pract. 2025 Mar 27;18(1):2480154. doi: 10.1080/20523211.2025.2480154. PMID: 40160496; PMCID: PMC11951331.
  10. Ibrahim A, Yusuff K, Awaisu A, Elewa H. Association between CYP2C19 polymorphism and proton pump inhibitors adverse drug reactions: a narrative review. Front Pharmacol. 2025 Feb 12;16:1523399. doi: 10.3389/fphar.2025.1523399. PMID: 40070570; PMCID: PMC11894441.
  11. Alrawashdeh H, Sethi A, Awaisu A, Mukhalalati B. Exploring the Desirable Attributes and Competencies of Pharmacy Clinical Preceptors: A Scoping Review. Pharmacy (Basel). 2025 Jan 15;13(1):5. doi: 10.3390/pharmacy13010005. PMID: 39846628; PMCID: PMC11755490.
  12. Allouch S, Ali RM, Seed Ahmed M, Akhtar S, Awaisu A, Bidmos M. Confidence in Prescribing Practices: Perspectives of Senior Medical Students and Recent Graduates at Qatar University. Adv Med Educ Pract. 2024 Dec 28;15:1325-1337. doi: 10.2147/AMEP.S476352. PMID: 39749317; PMCID: PMC11693852.
  13. Alnaimi SJ, Ajaj F, Awaisu A, Alhathal T, Mohammed S, Alhail M. Assessment of knowledge, perceptions, and readiness of healthcare professionals towards clinical pharmacogenomics implementation in Qatar: a mixed-method study. J Pharm Policy Pract. 2024 Nov 26;17(1):2429785. doi: 10.1080/20523211.2024.2429785. PMID: 39605985; PMCID: PMC11600515.
  14. Alyazeedi A, Stewart C, Soiza RL, Stewart D, Awaisu A, Ryan C, Alhail M, Aldarwish A, Myint PK. Enhancing medication management of older adults in Qatar: healthcare professionals’ perspectives on challenges, barriers and enabling solutions. Ther Adv Drug Saf. 2024 Oct 7;15:20420986241272846. doi: 10.1177/20420986241272846. PMID: 39421007; PMCID: PMC11483847.
  15. Ababneh R, Rachid O, Awaisu A, Alkilany AM. Utilization of the Transparent Peer Review Policy to Train Graduate Pharmacy Students on Scientific Critique. Am J Pharm Educ. 2024 Oct;88(10):101268. doi: 10.1016/j.ajpe.2024.101268. Epub 2024 Aug 22. PMID: 39178953.
  16. Makki M, Shafie AA, Awaisu A, Hussain R, Al Hail M, ElMotasim WM, Taha MYMA, Abdoun E, Al-Khuzaei NMJ, Salama G, Pallivalapila A, El Kassem W, Thomas B. Patients’ insights into unused medications during the COVID-19 outbreak: A qualitative study. Explor Res Clin Soc Pharm. 2024 Sep 26;16:100517. doi: 10.1016/j.rcsop.2024.100517. PMID: 39435401; PMCID: PMC11492333.
  17. Naser AY, Aboutaleb R, Khaleel A, Alsairafi ZK, Alwafi H, Qadus S, Itani R, El-Dahiyat F, Awaisu A, Awwad O, et al. Knowledge, attitude, and practices of pharmacy students in 7 Middle Eastern countries concerning antibiotic resistance: A cross-sectional study. Medicine (Baltimore). 2024 Sep 6;103(36):e39378. doi: 10.1097/MD.0000000000039378. PMID: 39252298; PMCID: PMC11384052.
  18. El-Awaisi A, Yakti OH, Elboshra AM, Jasim KH, AboAlward AF, Shalfawi RW, Awaisu A, Rainkie D, Al Mutawa N, Major S. Facilitators and barriers to interprofessional collaboration among health professionals in primary healthcare centers in Qatar: a qualitative exploration using the “Gears” model. BMC Prim Care. 2024 Aug 27;25(1):316. doi: 10.1186/s12875-024-02537-8. PMID: 39192182; PMCID: PMC11348528.
  19. Mukhalalati B, Aly A, Yakti O, Elshami S, Daud A, Awaisu A, Sethi A, El-Awaisi A, Stewart D, Abu-Hijleh MF, Austin Z. Examining the perception of undergraduate health professional students of their learning environment, learning experience and professional identity development: a mixed-methods study. BMC Med Educ. 2024 Aug 16;24(1):886. doi: 10.1186/s12909-024-05875-4. PMID: 39152424; PMCID: PMC11330008.
  20. Ageeb SA, Abdelmoghith A, ElGeed H, Awaisu A, ElMansor A, Owusu YB. Prevalence, Associated Risk Factors, and Adverse Cardiovascular Outcomes of Statins Discontinuation: A Systematic Review. Pharmacoepidemiol Drug Saf. 2024 Aug;33(8):e5879. doi: 10.1002/pds.5879. PMID: 39135516.
  21. Al-Sulaiti FK, Alkhiyami D, Elmekaty EZI, Awaisu A, Kheir N, El-Zubair A, Al-Sulaiti HK. Appropriateness of gentamicin therapeutic drug monitoring at a Middle Eastern tertiary hospital setting: a retrospective evaluation and quality audit. J Pharm Policy Pract. 2024 Jul 12;17(1):2375753. doi: 10.1080/20523211.2024.2375753. PMID: 39011355; PMCID: PMC11249166.
  22. Alalawneh M, Awaisu A, Abdallah I, Elewa H, Danjuma M, Matar KM, ElKashlan AM, Elshayep Y, Ibrahim F, Rachid O. Pharmacokinetics of single-dose rivaroxaban under fed state in obese vs. non-obese subjects: An open-label controlled clinical trial (RIVOBESE-PK). Clin Transl Sci. 2024 Jun;17(6):e13853. doi: 10.1111/cts.13853. PMID: 38847347; PMCID: PMC11157419.
  23. Aly A, Hishari O, Stewart D, Awaisu A, Elshami S, Mukhalalati B. Exploring the perceptions of faculty members about research courses in undergraduate pharmacy curriculum: A qualitative study. PLoS One. 2024 Jun 25;19(6):e0305946. doi: 10.1371/journal.pone.0305946. PMID: 38917131; PMCID: PMC11198811.
  24. Alyazeedi A, Sherbash M, Algendy AF, Stewart C, Soiza RL, Alhail M, Aldarwish A, Stewart D, Awaisu A, Ryan C, Myint PK. Enhancing Medication Safety through Implementing the Qatar Tool for Reducing Inappropriate Medication (QTRIM) in Ambulatory Older Adults. Healthcare (Basel). 2024 Jun 12;12(12):1186. doi: 10.3390/healthcare12121186. PMID: 38921300; PMCID: PMC11202920.
  25. Makki M, Akmal Shafie A, Awaisu A, Hussain R, Al Hail M, ElMotasim WM, Mohamed Ali Taha MY, Abdoun E, Al-Khuzaei NMJ, Salama G, Pallivalapila A, El Kassem W, Thomas B. Patients’ knowledge, attitude, and practices toward unused medications in Qatar: A cross-sectional survey. Heliyon. 2024 May 25;10(12):e31931. doi: 10.1016/j.heliyon.2024.e31931. PMID: 39015807; PMCID: PMC11250874.
  26. Rahhal A, Hamamyh T, Chapra A, Zaza KJ, Najim M, Hemadneh M, Faraj H, Kanjo W, Yasin A, Toba H, Mohammed W, Hamad MK, Al-Tikrety N, Baraa Habib M, Awaisu A, Mahfouz A, Alyafei S, Arabi AR, Patel A, Al-Hijji M. Sodium-glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure. Front Cardiovasc Med. 2024 May 20;11:1383669. doi: 10.3389/fcvm.2024.1383669. Erratum in: Front Cardiovasc Med. 2025 Mar 05;12:1580343. doi: 10.3389/fcvm.2025.1580343. PMID: 38832317; PMCID: PMC11144919.
  27. Kattan L, Promi T, ElGeed H, Hussein FN, Awaisu A, Yusuff KB. Pharmacy Students’ Perception of the Content and Delivery of Drug Information Training: A Mixed-Methods Study. Am J Pharm Educ. 2024 Apr;88(4):100690. doi: 10.1016/j.ajpe.2024.100690. Epub 2024 Mar 21. PMID: 38521389.
  28. Abuyousef S, Alnaimi S, Omar NE, Elajez R, Elmekaty E, Abdelfattah-Arafa E, Barazi R, Ghasoub R, Rahhal A, Hamou F, Al-Amri M, Karawia A, Ajaj F, Alkhawaja R, Kardousha A, Awaisu A, Abou-Ali A, Khatib M, Aboukamar M, Al-Hail M. Early predictors of intensive care unit admission among COVID-19 patients in Qatar. Front Public Health. 2024 Mar 20;12:1278046. doi: 10.3389/fpubh.2024.1278046. PMID: 38572008; PMCID: PMC10987715.
  29. Awad K, Jaam M, Awaisu A, Stewart D, Rathore HA, Abdul Hadi M. Impact of pharmaceutical care interventions in improving clinical outcomes among patients with pulmonary tuberculosis: a systematic review. J Pharm Policy Pract. 2024 Feb 7;17(1):2305770. doi: 10.1080/20523211.2024.2305770. PMID: 38333578; PMCID: PMC10851829.
  30. Zidan A, Awaisu A. Inappropriate polypharmacy management versus deprescribing: A review on their relationship. Basic Clin Pharmacol Toxicol. 2024 Jan;134(1):6-14. doi: 10.1111/bcpt.13920. Epub 2023 Jul 11. PMID: 37350370.
  31. Alalawneh M, Rachid O, Abdallah I, Mahfouz A, Elewa H, Danjuma MI, Mohamed AE, Awaisu A. Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data. Eur J Clin Pharmacol. 2023 Dec;79(12):1675-1685. doi: 10.1007/s00228-023-03572-7. Epub 2023 Oct 10. PMID: 37816816; PMCID: PMC10663176.
  32. ElKhalifa D, Al-Ziftawi N, Awaisu A, Alali F, Khalil A. Efficacy and tolerability of sulforaphane in the therapeutic management of cancers: a systematic review of randomized controlled trials. Front Oncol. 2023 Nov 24;13:1251895. doi: 10.3389/fonc.2023.1251895. PMID: 38074675; PMCID: PMC10710291.
  33. Abubakar U, Awaisu A, Khan AH, Alam K. Impact of COVID-19 Pandemic on Healthcare-Associated Infections: A Systematic Review and Meta-Analysis. Antibiotics (Basel). 2023 Nov 7;12(11):1600. doi: 10.3390/antibiotics12111600. PMID: 37998802; PMCID: PMC10668951.
  34. Ibrahim AKA, Syed Sulaiman SA, Awaisu A, Shafie AA. Impact of brief smoking cessation intervention on quitting rate and glycemic control in patients with diabetes: a randomized controlled trial. J Int Med Res. 2023 Oct;51(10):3000605231208598. doi: 10.1177/03000605231208598. PMID: 37890143; PMCID: PMC10612461.
  35. GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023 Jul 15;402(10397):203-234. doi: 10.1016/S0140-6736(23)01301-6. Epub 2023 Jun 22. PMID: 37356446
  36. Hiba Bawadi, Sara Elshami, Ahmed Awaisu, Ghadir Fakhri Al-Jayyousi, Shuja Ashfaq and Banan Mukhalalati. A review of technical and quality assessment considerations of audio-visual and web-conferencing focus groups in qualitative health research. Humanities and Social Sciences Communications. 2023,10, 563. https://doi.org/10.1057/s41599-023-01989-0
  37. Zidan A, Awaisu A. Inappropriate polypharmacy management versus deprescribing: A review on their relationship. Basic Clin Pharmacol Toxicol. 2023 Jun 23. doi: 10.1111/bcpt.13920. Epub ahead of print. PMID: 37350370.
  38. Al-Shaibi S, Abushanab D, Abounahia F, Awaisu A, Al-Badriyeh D. Cost-effectiveness analysis of ibuprofen versus indomethacin or paracetamol for the treatment of patent ductus arteriosus in preterm neonates. Curr Probl Cardiol. 2023 Sep;48(9):101751. doi: 10.1016/j.cpcardiol.2023.101751. Epub 2023 Apr 21. PMID: 37088173.
  39. Ahmed A, Dujaili JA, Chuah LH, Hashmi FK, Le LKD, Chatha ZF, Khanal S, Awaisu A, Chaiyakunapruk N. Cost-effectiveness analysis of pharmacist adherence interventions in people living with HIV/AIDS in Pakistan. Healthcare (Basel). 2023 Sep 1;11(17):2453. doi: 10.3390/healthcare11172453. PMID: 37685487
  40. Abdelkader NN, Awaisu A, Elewa H, El Hajj MS. Prescribing patterns of antihypertensive medications: A systematic review of literature between 2010 and 2020. Explor Res Clin Soc Pharm. 2023 Aug 5;11:100315. doi: 10.1016/j.rcsop.2023.100315. PMID: 37635839.
  41. Al-Mansouri A, Hamad AI, Al-Ali FS, Ibrahim MIM, Kheir N, Al-Ziftawi NH, Ibrahim RA, AlBakri M, Awaisu A. Pill-burden and its association with treatment burden among patients with advanced stages of chronic kidney disease. Saudi Pharm J. 2023 May;31(5):678-686. doi: 10.1016/j.jsps.2023.03.008. Epub 2023 Mar 18. PMID: 37181136
  42. El Hajj MS, Kaddoura R, Abu Yousef SEA, Orabi B, Awaisu A, AlYafei S, Shami R, Mahfoud ZR. Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-experimental study. Int J Clin Pharm. 2023 Jun;45(3):630-640. doi: 10.1007/s11096-023-01538-4. Epub 2023 Feb 16. PMID: 36795303
  43. Ahmed A, Dujaili JA, Chuah LH, Hashmi FK, Le LK, Khanal S, Awaisu A, Chaiyakunapruk N. Cost-effectiveness of anti-retroviral adherence interventions for people living with HIV: A systematic review of decision analytical models. Appl Health Econ Health Policy. 2023 Sep;21(5):731-750. doi: 10.1007/s40258-023-00818-4. Epub 2023 Jun 30. PMID: 37389788
  44. Ali RM, Zolezzi M, Awaisu A, Eltorki Y. Sleep Quality and Sleep Hygiene Behaviours Among University Students in Qatar. Int J Gen Med. 2023 Jun 13;16:2427-2439. doi: 10.2147/IJGM.S402399. PMID: 37333875; PMCID: PMC10276586.
  45. Elshami S, Awaisu A, Abidi R, Al-Ghazal L, Al-Hathal T, Basil M, Fakhr N, Yakti O, El-Awaisi A, Stewart D, Mraiche F, Diab M, Mukhalalati B. Examining Pharmacy Alumni Perceptions of Job Satisfaction, Achievements, and Preparedness: A Mixed-Methods Study. Am J Pharm Educ. 2023 May;87(5):100059. doi: 10.1016/j.ajpe.2023.100059. Epub 2023 Mar 15. PMID: 37288694.
  46. Mahmoud MA, Meyer JC, Awaisu A, Fadare J, Fathelrahman AI, Saleem F, Aljadhey H, Godman B. Editorial: Medication safety and interventions to reduce patient harm in low- and middle-income countries. Front Pharmacol. 2023 Jan 9;13:1124371. doi: 10.3389/fphar.2022.1124371. PMID: 36699062; PMCID: PMC9868153.
  47. Ibrahim SA, El Hajj MS, Owusu YB, Al-Khaja M, Khalifa A, Ahmed D, Awaisu A. Adherence as a predictor of glycemic control among adolescents with type 1 diabetes: A retrospective study using real-world evidence. Clin Ther. 2022 Oct;44(10):1380-1392. doi: 10.1016/j.clinthera.2022.09.003. Epub 2022 Oct 1. PMID: 36192263.
  48. Ahmed A, Tanveer M, Dujaili JA, Chuah LH, Hashmi FK, Awaisu A. Pharmacist-Involved Antiretroviral Stewardship Programs in People Living with HIV/AIDS: A Systematic Review. AIDS Patient Care STDS. 2023 Jan;37(1):31-52. doi: 10.1089/apc.2022.0192. PMID: 36626156.
  49. Elbashir M, ElHajj MS, Rainkie D, Kheir N, Hamou F, Abdulrhim S, Mahfouz A, Alyafei S, Awaisu A. Evaluation of health literacy levels and associated factors among patients with acute coronary syndrome and heart failure in Qatar. Patient Prefer Adherence. 2023 Jan 7;17:89-105. doi: 10.2147/PPA.S385246. PMID: 36642998; PMCID: PMC9835006.
  50. Alalawneh M, Awaisu A, Rachid O. Rivaroxaban pharmacokinetics in obese subjects: A systematic review. Clin Pharmacokinet. 2022 Dec;61(12):1677-1695. doi: 10.1007/s40262-022-01160-z. Epub 2022 Oct 6. PMID: 36201149
  51. Zaghloul N, Awaisu A, Mahfouz A, Alyafei S, Elewa H. A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country. Int J Clin Pharm. 2022 Dec;44(6):1342-1350. doi: 10.1007/s11096-022-01464-x. Epub 2022 Sep 28. PMID: 36169802
  52. Boura F, Awaisu A, ElGeed H, Katoue M, Kheir N. Pharmaceutical care education at pharmacy colleges in the Middle East and North Africa region: A systematic review. J Clin Pharm Ther. 2022 Aug;47(8):1134-1148. doi: 10.1111/jcpt.13674. Epub 2022 May 4. PMID: 35509234.
  53. Lok P, Beyene K, Awaisu A, Woods D, Kheir N. Microcredentials training in pharmacy practice and education: an exploratory study of its viability and pharmacists’ professional needs. BMC Med Educ. 2022 Apr 29;22(1):332. doi: 10.1186/s12909-022-03341-7. PMID: 35488266
  54. Mukhalalati B, Elshami S, Adlan O, Elshazly M, Awaisu A, Stewart D, Al-Badriyeh D, Alali F. Perceptions and experiences of undergraduate pharmacy students and alumni towards research after exposure to undergraduate research courses. Front Med. 2022 Sep 8;9:988908. doi: 10.3389/fmed.2022.988908. eCollection 2022. PMID: 36160160
  55. Sherif B, Awaisu A, Kheir N. Refugee healthcare needs and barriers to accessing healthcare services in New Zealand: a qualitative phenomenological approach. BMC Health Serv Res. 2022 Nov 3;22(1):1310. doi: 10.1186/s12913-022-08560-8. PMID: 36329410
  56. Alhmoud E, Al Khiyami D, Barazi R, Saad M, Al-Omari A, Awaisu A, El Enany R, Al Hail M. Perspectives of clinical pharmacists on the provision of pharmaceutical care through telepharmacy services during COVID-19 pandemic in Qatar: A focus group. PLoS One. 2022 Oct 13;17(10):e0275627. doi: 10.1371/journal.pone.0275627. PMID: 36228028; PMCID: PMC9560548.
  57. Ahmed A, Dujaili JA, Jabeen M, Umair MM, Chuah LH, Hashmi FK, Awaisu A, Chaiyakunapruk N. Barriers and enablers for adherence to antiretroviral therapy among people living with HIV/AIDS in the era of COVID-19: A qualitative study from Pakistan. Front Pharmacol. 2022 Jan 28;12:807446. doi: 10.3389/fphar.2021.807446. PMID: 35153763; PMCID: PMC8832364.
  58. Arafa EA, Dhayabaran V, Omar NE, Awaisu A. Rare case of norethisterone-induced hepatitis: A case report. Clin Case Rep. 2022;10:e05687. doi:10.1002/ccr3.5687
  59. Owusu YB, Elkhalifa WH, Awaisu A, Kheir N. Assessment of Qatar community pharmacists’ competence and practices related to renal and gastrointestinal adverse effects of nonprescription NSAIDs. Saudi Pharmaceutical Journal. 2022 Oct; 30 (10): 1396-1404. https://doi.org/10.1016/j.jsps.2022.06.011
  60. Makhlouf AM, Ibrahim MI, Awaisu A, Yusuff KB. Predictors of enablers and barriers to community pharmacists’ management of minor ailments in a developing setting: A theory-driven assessment. J Am Pharm Assoc (2003). 2023 Jan-Feb;63(1):58-65. doi: 10.1016/j.japh.2022.08.011. Epub 2022 Aug 18. PMID: 36109333.
  61. Mukhalalati B, Elshami S, Awaisu A, Al-Jayyousi G, Abu-Hijleh M, Paravattil B, Almahasneh R, Bawadi H, Al-Amri K, Al-Khal A. Implementation and evaluation of a preceptor educational development programme involving the health cluster colleges at Qatar University. Int J Health Plann Manage. Int J Health Plann Manage. 2022 Nov;37(6):3126-3147. doi: 10.1002/hpm.3544. Epub 2022 Jul 21. PMID: 35861383.
  62. El-Awaisi A, Al-Shaibi S, Al-Ansari R, Naseralallah L, Awaisu A. A systematic review on the impact of pharmacist-provided services on patients’ health outcomes in Arab countries. J Clin Pharm Ther. 2022 Jul;47(7):879-896. doi: 10.1111/jcpt.13633. Epub 2022 Mar 24. PMID: 35332557
  63. Elhag M, Awaisu A, Koenig HG, Mohamed Ibrahim MI. The association between religiosity, spirituality, and medication adherence among patients with cardiovascular diseases: a systematic review of the literature. J Relig Health. 2022 Oct;61(5):3988-4027. doi: 10.1007/s10943-022-01525-5. Epub 2022 Mar 10. PMID: 35274225
  64. Mukhalalati B, Awaisu A, Elshami, Paravattil B, Zolezzi M, Abu-Hijleh M, Moslih-Almoslih A, Carr A, Bawadi H, Romanowski M, Almahasneh, Bacha. Assessment of Educational Needs and Design of a Preceptor Development Program for Health Professional Education Programs in Qatar. J Contin Educ Health Prof. 2022 Jan 1;42(1):e32-e43. doi: 10.1097/CEH.0000000000000353. PMID: 34174045
  65. El Hajj MS, Awaisu A, Nik Mohamed MH, Saleh RA, Al Hamad NM, Kheir N, Mahfoud ZR. Assessment of an intensive education program for pharmacists on treatment of tobacco use disorder using an objective structured clinical examination: a randomized controlled trial. BMC Med Educ. 2022 Apr 18;22(1):289. doi: 10.1186/s12909-022-03331-9. PMID: 35436957
  66. Ali ZO, Bader L, Mohammed S, Arafa S, Arabi A, Cavallari L, Langaee T, Mraiche F, Rizk N, Awaisu A, Shahin MH, Elewa H. Effect of CYP2C19 genetic variants on bleeding and major adverse cardiovascular events in a cohort of Arab patients undergoing percutaneous coronary intervention and stent implantation. Pharmacogenet Genomics. 2022 Jul 1;32(5):183-191. doi: 10.1097/FPC.0000000000000469. Epub 2022 Apr 7. PMID: 35389962
  67. Jaam M, Awaisu A, El-Awaisi A, Stewart D, El Hajj MS. Use of the Delphi technique in pharmacy practice research. Res Social Adm Pharm. 2022 Jan;18(1):2237-2248. doi: 10.1016/j.sapharm.2021.06.028. Epub 2021 Aug 12. PMID: 34412997.
  68. ElGeed H, El Hajj MS, Ali R, Awaisu A. The utilization of simulated patients for teaching and learning in the pharmacy curriculum: exploring pharmacy students’ and recent alumni’s perceptions using mixed-methods approach. BMC Med Educ 21, 562 (2021). https://doi.org/10.1186/s12909-021-02977-1
  69. El Hajj MS, Sheikh Ali SAS, Awaisu A, Saleh R, Kheir N, Shami R. A pharmacist-delivered smoking cessation program in Qatar: an exploration of pharmacists’ and patients’ perspectives of the program. Int J Clin Pharm. 2021 Dec;43(6):1574-1583. doi: 10.1007/s11096-021-01286-3. Epub 2021 Jun 2. PMID: 34080087; PMCID: PMC8642383.
  70. Abbas A, Al-Shaibi S, Sankaralingam S, Awaisu A, Kattezhathu VS, Wongwiwatthananukit S, Owusu YB. Determination of potential drug-drug interactions in prescription orders dispensed in a community pharmacy setting using Micromedex® and Lexicomp®: a retrospective observational study. Int J Clin Pharm. 2022 Apr;44(2):348-356. doi: 10.1007/s11096-021-01346-8.
  71. Abdulrhim S, Awaisu A, Ibrahim MIM, Diab MI, Hussain MAM, Al Raey H, Ismail MT, Sankaralingam S. Impact of pharmacist-involved collaborative care on diabetes management in a primary healthcare setting using real-world data. Int J Clin Pharm. 2022 Feb;44(1):153-162. doi: 10.1007/s11096-021-01327-x.
  72. Rahhal A, Khir F, Orabi B, Chbib S, Al-Khalaila O, Abdelghani MS, Osman O, Ashour AA, Al-Awad M, Mahfouz A, Awaisu A, Aljundi AH, Alahmad Y, Alyafei S, Arabi AR. A Comparative Study of High-intensity Rosuvastatin Versus Atorvastatin Therapy Post-acute Coronary Syndrome Using Real-world Data. Curr Probl Cardiol. 2022 Jul;47(7):100956. doi: 10.1016/j.cpcardiol.2021.100956.
  73. Ahmed A, Abdulelah Dujaili J, Rehman IU, Chuah LH, Hashmi FK, Awaisu A, Chaiyakunapruk N. Effect of pharmacist care on clinical outcomes among people living with HIV/AIDS: A systematic review and meta-analysis. Res Social Adm Pharm. 2022 Jun;18(6):2962-2980. doi: 10.1016/j.sapharm.2021.07.020.
  74. Ahmed A, Dujaili JA, Hashmi FK, Awaisu A, Chaiyakunapruk N, Hasan SS. The economic impact of pharmacist care for people living with HIV/AIDS: A systematic review. Exploratory Research in Clinical and Social Pharmacy. 2021;3:100066. Doi: 10.1016/j.rcsop.2021.100066
  75. Abdulrhim S, Sankaralingam S, Ibrahim MIM, Diab MI, Hussain MAM, Al Raey H, Ismail MT, Awaisu A. Collaborative care model for diabetes in primary care settings in Qatar: A qualitative exploration among healthcare professionals and patients who experienced the service. BMC Health Serv Res. 2021 Mar 2;21(1):192. doi: 10.1186/s12913-021-06183-z.
  76. Al-mansouri A, Al-Ali FS, Hamad AI, Mohamed Ibrahim MI, Kheir N, Ibrahim RA, AlBakri M, Awaisu A. Assessment of treatment burden and its impact on quality of life in dialysis-dependent and pre-dialysis chronic kidney disease patients in Qatar. Res Social Adm Pharm. 2021. https://doi.org/10.1016/j.sapharm.2021.02.010.
  77. Ahmed A, Saqlain M, Bashir N, Dujaili J, Hashmi F, Mazhar F, Khan A, Jabeen A, Blebil A, Awaisu A. Health-related quality of life and its predictors among adults living with HIV/AIDS and receiving antiretroviral therapy in Pakistan. Qual Life Res. 2021 Jun;30(6):1653-1664. doi: 10.1007/s11136-021-02771-y.
  78. Owusu YB, Abouelhassan R, Awaisu A. Evaluation of patient safety culture in community pharmacies in Qatar. Int J Clin Pract. 2021 May;75(5):e14055. doi: 10.1111/ijcp.14055.
  79. ElGeed H, Owusu Y, Abdulrhim S, Awaisu A, Kattezhathu VS, Abdulrouf PV, Sankaralingam S. Evidence of community pharmacists’ response preparedness during COVID-19 public health crisis: A cross-sectional study. J Infect Dev Ctries. 2021 Jan 31;15(1):40-50. doi: 10.3855/jidc.13847.
  80. Al AdAwi RM, Albu-Mahmood Z, Abdelgelil M, Abdelaziz H, Stewart D, Awaisu A. Incidence of co-trimoxazole-induced hyperkalemia in a tertiary care hospital. Risk Manag Healthc Policy. 2021;14:519-525. https://doi.org/10.2147/RMHP.S283471
  81. El-Awaisi A, Awaisu A, Aboelbaha S, Abedini Z, Johnson J, Al-Abdulla SA. Perspectives of healthcare professionals toward interprofessional collaboration in primary care settings in a Middle Eastern country. J Multidiscip Healthc. 2021;14:363-379. https://doi.org/10.2147/JMDH.S286960
  82. Naser AY, Alsairafi ZK, Awaisu A, Alwafi H, Awwad O, Dahmash EZ, et al. Attitudes of pharmacy students towards patient safety: a cross-sectional study from six developing countries. BMJ Open. 2020 Dec 15;10(12):e039459. doi: 10.1136/bmjopen-2020-039459.
  83. Rahhal A, Khir F, Aljundi AH, AlAhmad Y, Alzaeem H, Habra M, Al-Shekh I, Mahfouz A, Awaisu A, Al-Yafei S, Arabi AR. Clinical outcomes of high-intensity doses of atorvastatin in patients with acute coronary syndrome: A retrospective cohort study using real-world data. Br J Clin Pharmacol. 2021 Apr;87(4):2043-2052. doi: 10.1111/bcp.14613.
  84. El Hajj MS, Jaam M, Sheikh Ali SAS, Saleh R, Awaisu A, Paravattil B, Wilby KJ. Critical appraisal of tobacco dependence treatment guidelines. Int J Clin Pharm. 2021;43(1):85-100. https://doi.org/10.1007/s11096-020-01110-4 
  85. El-Awaisi A, Sheikh Ali S, Abu Nada A, Rainkie D, Awaisu A. Insights from healthcare academics on facilitating interprofessional education activities. J Interprof Care. 2020 Sep 13;1-11. doi: 10.1080/13561820.2020.1811212. Online ahead of print.
  86. Mukhalalati B, Shahrour M, Rabie S, Awaisu A, Elshami S, Alali F. Cultural awareness and competence of pharmacy educators and learners from the perspective of pharmacy students at Qatar University: A mixed-methods approach. PLoS One. 2020 Dec 2;15(12):e0243095. doi: 10.1371/journal.pone.0243095. eCollection 2020.
  87. Arafat Y, Mohamed Ibrahim MI, Awaisu A, Owusu Y. Relationship between stages of change and glycemic control in patients with type 2 diabetes mellitus in a primary health-care setting. J Pharm Bioall Sci [serial online] 2020 [cited 2020 Oct 8];12:400-5. Available from: https://www.jpbsonline.org/text.asp?2020/12/4/400/297473
  88. Munsour EE, Awaisu A, Hassali MAA, Abdoun E, Dabbous Z, Zahran N, et al. The effect of tailored consumer medicine information on patients with type 2 diabetes mellitus: A randomised controlled interventional study. Int J Clin Pract.  2020;74(8). doi: 10.1111/ijcp.13527.
  89. Abdulrhim S, Sankaralingam S, Ibrahim MIM, Awaisu A. The impact of pharmacist care on diabetes outcomes in primary care settings: An umbrella review of published systematic reviews. Prim Care Diabetes. 2020 Oct;14(5):393-400. doi: 10.1016/j.pcd.2019.12.007.
  90. Munsour EE, Awaisu A, Ahmad Hassali MA, Dabbous Z, Zahran N, Abdoun E. Impact of customized-consumer medication information on health-related quality of life among patients with type 2 diabetes mellitus. Res Social Adm Pharm. 2020 Jun;16(6):793-799. doi: 10.1016/j.sapharm.2019.08.038.
  91. Munsour EE, Awaisu A, Hassali MAA, Ali H, Dabbous Z. A comparative evaluation of written medicine information of antidiabetic medicines from Qatar, Australia and Europe. Cogent Medicine. 2019;6(1):1620904. https://doi.org/10.1080/2331205X.2019.1620904    
  92. Ibrahim SA, ElHajj M, Zidan A, Owusu Y, Awaisu A. Barriers to Diabetes Adherence (BDA): Translation and cultural adaptation of the instrument into Arabic context. Value in Health Regional Issues. 2020;22:49-53.
  93. Jebara T, Cunningham S, MacLure K, Awaisu A, Pallivalapila A, Al Hail M, Stewart D. Health-related stakeholders’ perceptions of clinical pharmacy services in Qatar. Int J Clin Pharm. 2021 Feb;43(1):107-117. doi: 10.1007/s11096-020-01114-0.
  94. Albassam A, Alharbi A, Awaisu A. Assessing adherence to inhaled corticosteroids among adults with asthma in Kuwait using the Medication Adherence Report Scale for Asthma. Patient Preference and Adherence. 2020:14 1–8.
  95. Ali R, Zolezzi M, Awaisu A. A Systematic review of instruments for the assessment of insomnia in adults. Nature and Science of Sleep. 2020; 12: 377-409.
  96. Al-Sulaiti F, Fares H, Awaisu A, Kheir N. Continuing professional development needs of community pharmacists in Qatar: A Mixed-methods approach. Int Q Community Health Educ. 2021 Apr;41(3):285-292. doi: 10.1177/0272684X20918048.    
  97. Stewart D, MacLure K, Pallivalapila A, Dijkstra A, Wilbur K, Wilb  K, Awaisu A, McLay JS , Thomas B, Ryan C, El Kassem W, Singh R, Al Hail M.  Views and experiences of decision‐makers on organizational safety culture and medication errors. Int J Clin Pract. 2020; 74:e13560. https://doi.org/10.1111/ijcp.13560
  98. Abdallah O, Ageeb RA, Elkhalifa WHI, Zolezzi M, El-Awaisi A, Diab MI, Awaisu A. Evaluating prescribing competencies covered in a Canadian-accredited undergraduate pharmacy program in Qatar: a curriculum mapping process. BMC Medical Education. 2020;20:253. https://doi.org/10.1186/s12909-020-02109-1
  99. Diab MI, Ibrahim A, Abdallah O, El-Awaisi A, Zolezzi M, Ageeb RA, Elkhalifa WHI, Awaisu A. Perspectives of future pharmacists on the potential for development and implementation of pharmacist prescribing in Qatar. Int J Clin Pharm. 2020 Feb;42(1):110-123. doi: 10.1007/s11096-019-00946-9.
  100. Jebara T, Cunningham S, MacLure K, Pallivalapila A, Awaisu A, Al Hail M, et al. A modified-Delphi study of a framework to support the potential implementation of pharmacist prescribing. Res Social Adm Pharm. 2020;16(6):812-818. doi: 10.1016/j.sapharm.2019.09.005.
  101. Jebara T, Cunningham S, MacLure K, Pallivalapila A, Awaisu A, Al Hail M, et al. Key stakeholders’ views on the potential implementation of pharmacist prescribing: A qualitative investigation. Res Social Adm Pharm. 2020 Mar;16(3):405-414. doi: 10.1016/j.sapharm.2019.06.009.
  102. El-Awaisi A, Awaisu A, Jaam M, Saffouh El Hajj M, Verjee MA. Does the delivery of interprofessional education have an effect on stereotypical views of healthcare students in Qatar? Journal of Interprofessional Care. 2020 Jan-Feb;34(1):44-49. doi: 10.1080/13561820.2019.1612863.
  103. Elbashir M, Awaisu A, El Hajj MS, Rainkie DC. Measurement of health literacy in patients with cardiovascular diseases: A systematic review. Res Social Adm Pharm. 2019 Dec;15(12):1395-1405. doi: 10.1016/j.sapharm.2019.01.008.
  104. Elewa H, Awaisu A. Pharmacogenomics in Pharmacy Practice: Current Perspectives. Integrated Pharmacy Research & Practice. 2019;8:97-104.
  105. Kheir N, Awaisu A, Ibrahim S, Al-Dulaimi SM, Gad H. Perspectives of pharmacy graduates toward an undergraduate ethics course and its potential impact on their professional practice. Advances in Medical Education and Practice. 2019 Dec;10:1047-56. doi: 10.2147/AMEP.S224093
  106. Al-Sulaiti FK, Nader A, El-Mekaty E, Elewa H, Al-Badriyeh D, El-Zubair A, Saad MO, Awaisu A. Vancomycin therapeutic drug monitoring service quality indices and clinical effectiveness outcomes: A retrospective cohort and clinical audit.  J Am Coll Clin Pharm. 2020; 3: 778– 785. https://doi.org/10.1002/jac5.1223
  107. Al-Sulaiti FK, Nader AM, Saad MO, Shaukat A, Parakadavathu R, Elzubair A, Al-Badriyeh D, Elewa H, Awaisu A. Clinical and pharmacokinetic outcomes of peak-trough-based versus trough-based vancomycin therapeutic drug monitoring approaches: A pragmatic randomized controlled trial. European Journal of Drug Metabolism and Pharmacokinetics. 2019 Oct;44(5):639-652. DOI: 10.1007/s13318-019-00551-1.
  108. Jatau AI, Shitu Z, Khalid GM, Yunusa I, Awaisu A. Understanding adverse drug-related emergency department visits: Development of a conceptual model through a systematic review. Therapeutic Advances in Drug Safety. 2019;10:2042098619852552. doi: 10.1177/2042098619852552. (Available online: 24 June 2019)
  109. Makki M, Hassali MA, Awaisu A, Hashmi F. The prevalence of unused medications in homes. Pharmacy (Basel). 2019 Jun;7(2): 61. DOI: 10.3390/pharmacy7020061. (Available online: 13 Jun 2019).
  110. Abdulrhim SH, Saleh RA, Mohamed Hussain MA, Al Raey H, Babiker AH, Kheir N, Awaisu A. Impact of a collaborative pharmaceutical care service among patients with diabetes in an ambulatory care setting in Qatar: A multiple time series study. Value in Health Regional Issues. 2019 Sep;19:45-50. doi: 10.1016/j.vhri.2018.12.002.
  111. Arafat Y, Mohamed Ibrahim MI, Awaisu A, Colagiuri S, Owusu Y, Morisky DE, AlHafiz M, Yousif A. Using the transtheoretical model’s stages of change to predict medication adherence in patients with type 2 diabetes mellitus in a primary health care setting. DARU Journal of Pharmaceutical Sciences. 2019;27(1):91-9. https://doi.org/10.1007/s40199-019-00246-7. In press 2019
  112. El Hajj MS, Awaisu A, Kheir N, Mohamed MHN, Haddad RS, Saleh RA, et al. Evaluation of an intensive education program on the treatment of tobacco-use disorder for pharmacists: A study protocol for a randomized controlled trial. Trials. 2019;20(1):25.
  113. Awaisu A, Khalifa S, Mottram D, Ahmed A, Stuart M. Instructional design and assessment of an elective course on the use of drugs in sport. Currents in Pharmacy Teaching & Learning. 2018;10(8):1124-31.
  114. Awaisu A, Niewada M, Greenberg D. Drug policy research and health technology assessment in Central and Eastern Europe, Western Asia, and Africa: The interface between research evidence, policy, and practice. Value in Health Regional Issues. 2018;16:119-20.
  115. El Hajj MS, Awaisu A, Kheir N, Mohamed MHN, Haddad RS, Saleh RA, et al. Evaluation of an intensive education program on the treatment of tobacco-use disorder for pharmacists: A study protocol for a randomized controlled trial. Trials. 2019;20(1):25.
  116. Jaam M, Hadi MA, Kheir N, Mohamed Ibrahim MI, Diab MI,  Al–Abdulla S, Awaisu A. A qualitative exploration of barriers to medication adherence among patients with uncontrolled diabetes in Qatar: Integrating perspectives of patients and healthcare providers. Patient Preference and Adherence. Patient Preference and Adherence 2018;12: 2205–2216.
  117. Saad A, Akinsulie B, Egac C, Akiode A, Awaisu A. Misconception and current use of contraception among women of reproductive age in six major cities in Nigeria. European Journal of Contraception and Reproductive Health Care. 2018;23(6):415-420. https://doi.org/10.1080/13625187.2018.1533546
  118. Stewart D, Thomas B, MacLure K, Wilbur K, Wilby K, Pallivalapila A, Dijkstra A, Ryan C, El Kassem W, Awaisu A, et al. Exploring facilitators and barriers to medication error reporting among healthcare professionals in Qatar using the theoretical domains framework: A mixed–methods approach. PLoS ONE 2018;13(10): e0204987. https://doi.org/10.1371/journal.pone.0204987
  119. Stewart D, Thomas B, MacLure K, Pallivalapila A, El Kassem W, Awaisu A, et al. Perspectives of healthcare professionals in Qatar on causes of medication errors: A mixed methods study of safety culture. PLoS ONE 2018;13(9): e0204801. https://doi.org/10.1371/journal. pone.0204801
  120. Awaisu A, Katoue M, Al–Taweel D, Bacha R, El–Gargawi A, Kheir N. Self–reported attitudes and perceived preparedness to provide pharmaceutical care among final year pharmacy students in Qatar and Kuwait. Pharmacy Educ. 2018; 18(1): 284 – 291.
  121. Jatau AI, Ming LC, Awaisu A. Quality assurance, accreditation, and glocalisation of pharmacy programmes. Pharmacy Educ. 2018; 18(1):149 – 150.
  122. Alsalimy N, Madi L, Awaisu A. Efficacy and safety of laxatives for chronic constipation in long–term care settings: A systematic review. Journal of Clinical Pharmacy and Therapeutics. 2018;43(5):595–605. doi:10.1111/jcpt.12721
  123. Zidan A, Awaisu A, El–Hajj MS, Al–Abdulla SA, Figueroa DCR, Kheir N. Medication–related burden among patients with chronic disease conditions: Perspectives of patients attending non–communicable disease clinics in a primary healthcare setting in Qatar. Pharmacy (Basel). 2018; 6(3). doi:10.3390/pharmacy6030085.
  124. Jebara T, Cunningham S, MacLure K, Awaisu A, Pallivalapila A, Stewart D. Stakeholders’ views and experiences of pharmacist prescribing: A systematic review. British Journal of Clinical Pharmacology. 2018;84(9):1883–1905. doi:10.1111/bcp.13624
  125. Awaisu A, Khalifa S, Mottram D, Ahmed A, Stuart M. Instructional design and assessment of an elective course on the use of drugs in sport. Currents in Pharmacy Teaching and Learning. 2018;10:1124–1131. doi:https://doi.org/10.1016/j.cptl.2018.05.020
  126. Jatau AI, Isa A, Ado B, Sha’aban A, Awaisu A. Interventions to prevent emergency department visit related to complementary and alternative medicines use. J Complement Med Res. 2018;8(1):28–31.
  127. Mohamed Ibrahim MI, Awaisu A, Palaian S, Radoui A, Atwa H. Do community pharmacists in Qatar manage acute respiratory conditions rationally? A simulated client study. Journal of Pharmaceutical Health Services Research. 2018;9(1):33–39. doi:10.1111/jphs.12204
  128. El Hajj MS, Jaam MJ, Awaisu A. Effect of pharmacist care on medication adherence and cardiovascular outcomes among patients post–acute coronary syndrome: A systematic review. Research in Social & Administrative Pharmacy. 2018;14(6):507–20. doi:10.1016/j.sapharm.2017.06.004
  129. El Hajj MS, Awaisu A, Saleh RA, Al Hamad NM, Kheir N, Zeenny RM, Fathelrahman AI. Tobacco–related education in schools of pharmacy in the Middle East: A multinational cross–sectional study. Nicotine & Tobacco Research. 2018;20(5):561–7. doi:10.1093/ntr/ntx031
  130. Albaroodi KAI, Syed Sulaiman SA, Awaisu A. Evaluating the effect of glycaemic control, blood pressure, lipid profile and diabetes duration on developing diabetes complications and its progression. J. Pharm. Sci. & Res. 2018; 10(6):1395–1399.
  131. Jaam M, Mohamed Ibrahim MI, Kheir N, Hadi MA, Diab MI, Awaisu A. Assessing prevalence of and barriers to medication adherence in patients with uncontrolled diabetes attending primary healthcare clinics in Qatar. Prim Care Diabetes. 2018;12:116–125. doi: 10.1016/j.pcd.2017.11.001. 
  132. Jaam M, Awaisu A, Mohamed Ibrahim MI, Kheir N. Synthesizing and appraising the quality of the evidence on factors associated with medication adherence in diabetes: a systematic review of systematic reviews. Value Health Reg Issues. 2017;13:82–91. doi: 10.1016/j.vhri.2017.09.001. 
  133. Al Subeh Z, Alali F, Awaisu A. Attitudes towards using smart devices and medical applications among pharmacy students, preceptors and faculty members in Jordan. Pharmacy Education, 2017;17 (1) 308 – 315.
  134. Greenberg D, Boncz I, Awaisu A. Advancing the visibility, impact, and quality metrics of Value In Health Regional Issues (2017). Value Health Reg Issues. 2017;13:71–72. doi: 10.1016/j.vhri.2017.08.007.
  135. Rahhal AA, Awaisu A, Tawengi KM, AbuYousef S, Mekideche L. Prevalence and predictors of digoxin utilization among heart failure patients with reduced ejection fraction in Qatar.  Int J Clin Pharm. 2017;39(5):1070–1083. doi: 10.1007/s11096–017–0526–3.
  136. El–Awaisi A, Awaisu A, El Hajj MS, Alemrayat B, Al–Jayyousi G, Wong N, Verjee MA. Delivering tobacco cessation content in the Middle East through interprofessional learning. Am J Pharm Educ. 2017; 81 (5) Article 91.
  137. Jaam M, Awaisu A, Mohamed Ibrahim MI, Kheir N. A holistic conceptual framework model to describe medication adherence in and guide interventions in diabetes mellitus, Res Soc Admin Pharm. 2018; 14 : 391–397. http://dx.doi.org/10.1016/j.sapharm.2017.05.003.
  138. Jaam M, Ibrahim MIM, Kheir N, Awaisu A. Factors associated with medication adherence among patients with diabetes in the Middle East and North Africa region: A systematic mixed studies review. Diabetes Res Clin Pract. 2017;129:1–15. doi: http://dx.doi.org/10.1016/j.diabres. 2017.04.015 
  139. AlSaad D, Awaisu A, Elsalem S, Abdulrouf PV, Thomas B, AlHail M. Is pyridoxine effective and safe for post–partum lactation inhibition? A systematic review. J Clin Pharm Ther. 2017; 42(4):373–382. https://doi.org/10.1111/jcpt.12526 
  140. Munsour EE, Awaisu A, Hassali MA, Darwish S, Abdoun E. Readability and comprehensibility of patient information leaflets for antidiabetic medications in Qatar. J Pharm Technol. 2017;33(4):128–136. doi:10.1177/8755122517706978  
  141. Alsalimy N, Elkhalifa D, Shammaa AA, Magdy M, Awaisu A. Characteristics and quality of adverse drug reaction reporting: a comparison of pharmacists with other healthcare providers at a multi–specialty hospital in Qatar. Drugs Ther Perspect. 2017;33(6):283–289. DOI 10.1007/s40267–017–0404–z
  142. Stewart D, Jebara T, Cunningham S, Awaisu A, Abdulrouf PV, MacLure K. Future perspectives on nonmedical prescribing. Ther Adv Drug Saf. 2017;8(6):183–197. https://doi.org/10.1177/2042098617693546
  143. El–Awaisi A, Wilby KJ, Wilbur K, El Hajj MS, Awaisu A, Paravattil B. A Middle Eastern journey of integrating Interprofessional Education into the healthcare curriculum: a SWOC analysis. BMC Med Educ. 2017 Jan 17;17(1):15. doi: 10.1186/s12909–016–0852–5.
  144. Awaisu A, Hamou F, Mekideche L, El Muabby N, Mahfouz A, Mohammed S, Saad A. Proton pump inhibitor co–prescription with dual antiplatelet therapy among patients with acute coronary syndrome in Qatar. Int J Clin Pharm. 2016;38(2):353–361. doi: 10.1007/s11096–016–0250–4.
  145. Zidan A, Awaisu A, Kheir N, Mahfoud Z, Kaddoura R, AlYafei S, El Hajj MS. Impact of a pharmacist–delivered discharge and follow–up intervention for patients with acute coronary syndromes in Qatar: a study protocol for a randomised controlled trial. BMJ Open. 2016;6(11):e012141. doi: 10.1136/bmjopen–2016–012141.
  146. Zidan A, Awaisu A, Hasan S, Kheir N. The Living with Medicines Questionnaire: Translation and Cultural Adaptation into the Arabic Context. Value Health Reg Issues. 2016;10C:36–40. doi: 10.1016/j.vhri.2016.07.001.
  147. Elewa HF, AbdelSamad O, Elmubark AE, Al–Taweel HM, Mohamed A, Kheir N, Mohamed Ibrahim MI, Awaisu A. The first pharmacist–managed anticoagulation clinic under a collaborative practice agreement in Qatar: clinical and patient–oriented outcomes. J Clin Pharm Ther 2016;41(4):403–408. doi: 10.1111/jcpt.12400
  148. Arafat Y, Ibrahim MIM, Awaisu A. Role of pharmacists in the application of the transtheoretical model approach to enhance medication adherence in chronic diseases. J Pharm Pract Res. 2016; 46 (4): 338–341. doi: 10.1002/jppr.1198
  149. Arafat Y, Ibrahim MIM, Awaisu A. Using the transtheoretical model to enhance self‐management activities in patients with type 2 diabetes: a systematic review. J Pharm Health Serv Res. 2016; 7 (3): 149–156.
  150. Dujaili JA, Syed Sulaiman SA, Awaisu A, Hassali MA, Blebil AQ, Bredle JM. Comparability of interviewer–administration versus self–administration of the Functional Assessment of Chronic Illness Therapy–Tuberculosis (FACIT–TB) health–related quality of life questionnaire in pulmonary tuberculosis patients. Pulmonary Therapy. 2016; 2 (1): 127–137. doi: 10.1007/s41030–016–0016–0
  151. Mottram D, Khalifa S, Alemrayat B, Rahhal A, Ahmed A, Stuart M, Awaisu A. Perspective of pharmacists in Qatar regarding doping and anti–doping in sports. J Sports Med Phys Fitness. 2016;56(6):817–24.
  152. Jaam M, Al–Marridi W, Fares H, Izham M, Kheir N, Awaisu A. Perception and intentions to quit among waterpipe smokers in Qatar: a cross–sectional survey. Public Health Action. 2016; 6 (1): 38–43. http://dx.doi.org/10.5588/pha.15.0054
  153. Awaisu A, Mottram D, Rahhal A, Alemrayat B, Ahmed A, Stuart M, Khalifa S. Knowledge and perceptions  of pharmacy students in Qatar regarding doping and anti–doping in sport and on integration of sports pharmacy into  undergraduate pharmacy curricula. Am J Pharm Educ. 2015; 79 (8) Article 119.
  154. Kheir N, Awaisu A, Gad H, Elazzazy S, Jibril F, Gajam M. Clinical pharmacokinetics: perceptions of hospital pharmacists in Qatar about how it was taught and how it is applied. Int J Clin Pharm. 2015;37(6):1180–1187. doi:10.1007/s11096–015–0183–3.
  155. Awaisu A, Kheir N, Alrowashdeh HA, Allouch SN, Jebara T, Zaidan M, Mohamed Ibrahim MI. Impact of a pharmacy practice research capacity–building programme on improving the research abilities of pharmacists at two specialised tertiary care hospitals in Qatar: a preliminary study. J Pharm Health Serv Res 2015;6 (3):155–164.
  156. Awaisu A and Pawluk S. Patient assessment teaching and learning in undergraduate pharmacy curriculum: students’ perspective of a pharmacist–physician instructional strategy. Pharm Educ. 2015;15(1):127–130.
  157. Kheir N, Awaisu A, Ndoye A, Wilby KJ. Structured Multi–Skill Assessment (SMSA) in pharmacy: A contextual adaptation for authentic assessment for colleges of pharmacy and beyond. Avicenna 2015:5 http://dx.doi.org/10.5339/avi.2015.5
  158. Awaisu A, Bakdach D, Elajez RH, Zaidan M. Hospital pharmacists’ self–evaluation of their competence and confidence in conducting pharmacy practice research. Saudi Pharm J. 2015; 23(3): 257–265. doi: 10.1016/j.jsps.2014.10.002.
  159. Awaisu A, Alsalimy N. Pharmacists’ involvement in and attitudes towards pharmacy practice research: a systematic review of the literature. Res Soc Admin Pharm. 2015;11(6):725–748. doi: 10.1016/j.sapharm.2014.12.008.
  160. Awaisu A, Kheir N, Mohamed Ibrahim MI, El–Hajj M, Hazi H, Khudair N, Barazi R. Knowledge, attitudes, and practices of community pharmacists on generic medicines in Qatar. Int J Clin Pharm. 2014;36(2):394–404. DOI 10.1007/s11096–013–9909–2.
  161. Al–Salimy N, Awaisu A. Methoxy polyethylene glycol–epoetin beta versus darbepoetin alfa for anemia in non–dialysis–dependent CKD: a systematic review. Int J Clin Pharm. 2014;36(6):1115–25. DOI: 10.1007/s11096–014–0023–x.
  162. Babiker AH, Carson L, Awaisu A. Medication use review in Qatar: Are community pharmacists prepared for the extended professional role? Int J Clin Pharm. 2014;36(6):1241–50. DOI: 10.1007/s11096–014–0025–8.
  163. Abdulelah J, Sulaiman SAS, Hassali MA, Blebil AQ, Awaisu A, Bredle JM. Development and psychometric properties of a tuberculosis–specific multidimensional health–related quality–of–life measure for patients with pulmonary tuberculosis. Value Health. 2015; 6C:53–59.
  164. Kheir N, Awaisu A, Sharfi A, Kida M, Adam A. Drug–related problems identified by pharmacists conducting medication use reviews at a primary health center in Qatar. Int J Clin Pharm. 2014;36(4):702–6. DOI: 10.1007/s11096–014–9962–5.
  165. Dujaili JA, Sulaiman SAS, Hassali MA, Awaisu A, Blebil AQ, Bredle JM. Health–related quality of life as a predictor of tuberculosis treatment outcomes in Iraq. Int J Infect Dis. 2015;31:4–8. DOI: 10.1016/j.ijid.2014.12.004. 
  166. Stewart D, Al Hail M, Abdul Rouf PV, El Kassem W, Diack L, Thomas B, Awaisu A. Building hospital pharmacy practice research capacity in Qatar: a cross–sectional survey of hospital pharmacists. Int J Clin Pharm. 2015;37(3):511–521. doi: 10.1007/s11096–015–0087–2.
  167. Albaroodi K, Syed Sulaiman SA, Shafie AA, Awaisu A, Lajis R, Aziz NA. The development, translation and validation of an instrument used in a tobacco cessation intervention study among patients with diabetes. AJCPR. 2014;7(5): 1 – 4.
  168. Mohamed Ibrahim MI, Awaisu A, Atwa H, Radoui A, Kheir N, Maarup N. How do community pharmacist s in Qatar respond to patients presenting with symptoms of acute respiratory tract infections? Journal of Pharmacy Practice and Research. 2014; 44(1):62–63.
  169. Kheir N, Awaisu A, Radoui A, El Badawi A,  Jean L, Dowse R. Development and evaluation of pictograms on medication labels for patients with limited literacy skills in a culturally diverse multiethnic population. Res Soc Admin Pharm. 2014;10 (5):720–730. http://dx.doi.org/10.1016/j.sapharm.2013.11.003.
  170. Awaisu A, Hagi A, Ashour MA, Kheir N. Pictorial health warnings on cigarette packages in Qatar: preimplementation awareness and perceptions of ever–smokers versus never–smokers. Nicotine Tob Res. 2013;15(10);1765–1772. DOI: 10.1093/ntr/ntt059.
  171. Saad A, Rampal L, Sabitu K, AbdulRahman H, Awaisu A, AbuSamah B, Ibrahim A.  Impact of a customized peer–facilitators training program related to sexual health intervention. International Health 2012;4:277–282.
  172. Albaroodi K.A.I., Syed Sulaiman S.A, Awaisu A. Evaluation of the most commonly used anti–diabetic drugs at a hospital in northern part of Peninsular Malaysia. International Journal of Medical and Pharmaceutical Sciences. 2013;3(6):20–29.
  173. Dujaili J.A., Awaisu A., Blebil A.Q., Bredle J., Dujaili M.A., Hassali M.A., Syed Sulaiman S.A. Development of a Multi–Dimensional Health Related Quality of Life Measure Specific for Pulmonary Tuberculosis Patients in Iraq. Value in Health 2013;16(3): A95 – A96. 
  174. Dujaili J.A., Blebil A.Q., Dujaili M.A., Awaisu A., M.A. Hassali M.A., Syed Sulaiman S.A. Prevelance Of Pulmonary Tuberculosis And Multi Drug Resistant Tuberculosis Patients In Baghdad, Iraq. Value in Health 2013;16(3):A82.
  175. Awaisu A, Nik Mohamed MH, Noordin NM, Muttalif AR, Abd. Aziz N, Syed Sulaiman SA, Mahayiddin AA. Impact of connecting tuberculosis directly observed therapy short–course with smoking cessation on health–related quality of life. Tobacco Induced Diseases 2012;10:2. DOI:10.1186/1617–9625–10–2.
  176. Saad A, Lekhraj R, Sabitu K, AbdulRahman H, Awaisu A, Abu Samah B, Ibrahim A. An HIV–STI risk reduction program among undergraduate students at a northern Nigerian university: a randomized controlled field trial. J Public Health 2012. DOI 10.1007/s10389–012–0491–1.
  177. Awaisu A, Nik Mohamed MH, Noordin NM, Abd. Aziz N, Syed Sulaiman SA, Muttalif AR, Mahayiddin AA. The SCIDOTS Project: Evidence of benefits of an integrated tobacco cessation intervention in tuberculosis care on treatment outcomes. Substance Abuse Treatment, Prevention, and Policy 2011;6:26. DOI:10.1186/1747–597X–6–26.
  178. Awaisu A, Nik Mohamed MH, Noordin NM, Abd. Aziz N, Syed Sulaiman SA, Mahayiddin AA, Muttalif AR. Does connecting tobacco cessation intervention in tuberculosis care improve quality of life outcomes? Value in Health 2011;14(7):A283.
  179. Al–Dulaimy SN, Hassali MA, Awaisu A. An evaluation of senior pharmacy students’ perceptions and knowledge of complementary and alternative medicine at a Malaysian University. JATMS 2012; 18(1):41–43.
  180. Abdulelah JD, Syed Sulaiman SA, Awaisu A, Muttalif AR, Blebil AQ. Outcomes of tuberculosis treatment: a retrospective cohort analysis of smoking versus non–smoking patients in Penang, Malaysia.  J Public Health 2011; 19 (2):183–189. DOI: 10.1007/ s10389–010–0365–3.
  181. Matalqah L, Radaideh K, Yusoff ZM, Awaisu A. Predictors of breast cancer among women in a northern state of Malaysia: a matched case–control study. Asian Pacific J Cancer Prev 2011;12(6):1549–1553.
  182. Abdul Hadi M, Long CM, Awaisu A. Primary prevention for cardiovascular diseases: can statins replace aspirin? Med Princ Pract 2011;20:584. DOI: 10.1159/000330033
  183. Abd. Aziz N, Chue MC, Yong CY, Hassan Y, Awaisu A, Hassan J, Kamaruzaman MH. Efficacy and safety of dexmedetomidine versus morphine in post–operative cardiac surgery patients. Int J Clin Pharm 2011;33:150–154. DOI: 10.1007/s11096–011–9480–7.
  184. Oh AL, Hassali MA, Al–Haddad MS, Syed Sulaiman SA, Shafie AA, Awaisu A, Abdul Hadi M, Al–Haddad M. Public knowledge and attitudes towards antibiotic usage: a cross–sectional study among the general public in the state of Penang, Malaysia. J Infect Dev Ctries 2011; 5(5):338–347.
  185. Zakaria SF, Awaisu A. Shared–learning experience during a clinical pharmacy practice experience. Am J Pharm Educ. 2011;75 (4): Article 75.
  186. Long CM, Hassali MA, Shafie AA, Awaisu A, Abdul Hadi M, Al–Haddad M. Perspectives of heart failure patients in Malaysia towards medications and disease state management: findings from a qualitative study. J Public Health 2011;19:569–577. DOI 10.1007/s10389–011–0415–5.
  187. Matalqah L, Radaideh K, Yusoff ZM, Awaisu A. Health–related quality of life using EQ–5D among breast cancer survivors in comparison with age–matched peers from the general population in the state of Penang, Malaysia. J Public Health 2011;19:475–480. DOI 10.1007/s10389–011–0406–6.
  188. Elkalmi RM, Hassali MA, Ibrahim MI, Siow YL, Awaisu A. A qualitative study exploring barriers and facilitators for reporting of adverse drug reactions (ADRs) among community pharmacists in Malaysia. JPHSR 2011;2:71–78. DOI 10.1111/j.1759–8893.2011.00037.x
  189. AwaisuA, Samsudin S, AmirN, OmarCG, HashimMI, Nik MohamedMH, ShafieAA, HassaliMA. Measurement of Nicotine Withdrawal Symptoms: Linguistic Validation of the Wisconsin Smoking Withdrawal Scale (WSWS) in Malay.BMC Medical Research Methodology. 2010, 10:46. doi:10.1186/1471–2288–10–46.
  190. Hadi MA, Awaisu A. Post Graduate Programs in Clinical Pharmacy and Pharmacy Practice: Are We Heading in the Right Direction? Am J Pharm Educ. 2010; 74 (4): Article 72.
  191. Awaisu A, Nik Mohamed MH, Abd. Aziz N, Syed Sulaiman SA, Noordin NM, Muttalif AR, and Mahayiddin AA. Tobacco Use Prevalence, Knowledge, and Attitudes among Newly Diagnosed Tuberculosis Patients in Penang State and Wilayah Persekutuan Kuala Lumpur, Malaysia.Tobacco–induced Diseases 2010, 8:3. doi:10.1186/1617–9625–8–3.
  192. Awaisu A, Nik Mohamed MH, Noordin NM, Abd. Aziz N, Syed Sulaiman SA, Muttalif AR, Mahayiddin AA.Potential Impact of a Pilot Training Program on Smoking Cessation Intervention for Tuberculosis DOTS Providers in Malaysia. J Public Health 2010; 18:279–288. doi: 10.1007/s10389–009–0302–5.
  193. Awaisu A, Abd Rahman NS, Nik Mohamed MH, Rahman Bux SH, Mohamed Nazar NI. Malaysian Pharmacy Students’ Assessment of an Objective Structured Clinical Examination (OSCE). Am J Pharm Educ. 2010; 74 (2): Article 34.
  194. Awaisu A, Nik Mohamed MH. Advances in Pharmaceutical Education: An Experience with the Development and Implementation of an Objective Structured Clinical Examination (OSCE) in an Undergraduate Pharmacy Program.Pharm Educ 2010; 10 (1):32–38.
  195. Hassali MA, Shafie AA, Al–Haddad M, Balamurugan T, Awaisu A, Siow YL. A qualitative study exploring the impact of the pharmaceutical price war among community pharmacies in the state of penang, Malaysia. Journal of Clinical and Diagnostic Research. 2010; 4:3161–3169.
  196. Neoh CF, Hassali MA, Shafie AA, Awaisu A. Nature and adequacy of information on dispensed medications delivered to patients in community pharmacies: a pilot study from Penang Malaysia. JPHSR. 2010; DOI 10.1111/j.1759–8893.2010.00026.x.
  197. Awaisu A, Nik Mohamed MH, Mohamad Noordin N et al. Newly Diagnosed Tuberculosis Patients and Tobacco Use in North Malaysia. Int J Infect Dis 2010;14S1. doi:10.1016/j.ijid.2010.02.1814. Available electronically at http://www.ijidonline.com/
  198. Alefan Q, Nik Mohamed MH, Awaisu A, Razak T, Rahman JA. Students’ Perspectives on Pharmacy Curriculum in a Malaysian University. Mal J Pharm Sci. 2009;7(2):125–136.
  199. Hadi MA, Hassali MA, Shafie AA, Awaisu A. Evaluation of Breast Cancer Awareness among Female University Students in Malaysia.Pharm Pract 2010; 8(1):29–34.
  200. Hassali MA, Shafie AA, Awaisu A, Ping CC, Mohamed Ibrahim MI, Jamshed S. Physicians’ Views on Generic Medicines: A Narrative Review. JGM 2010; 7(1): 30–39. doi:10.1057/jgm.2009.32.
  201. Permala J, Hassali MA, Awaisu A, Shafie AA. Dosing Information in a Standard Drug Reference: Are Pediatrics Still Therapeutically Neglected? Pediatr Intern 2010; 52: 290–295. doi: 10.1111/j.1442–200X.2009.02958.x.
  202. Babar Z, Awaisu A. Evaluating Community Pharmacists’ Perceptions and Practices on Generic Medicines: A Pilot Study from Peninsular Malaysia. Journal of Generic Medicines. 2010; 7(1):30–39. doi: 10.1057/jgm.2008.10.
  203. Abdul Hadi M, Hassali MA, Shafie AA, Awaisu A. Knowledge and Perception of Breast Cancer among Women of Various Ethnic Groups in the State of Penang: A Cross–Sectional Survey.Med Princ and Pract 2010;19:61–67. doi: 10.1159/000252837.
  204. G.N. Chua, Hassali MA, Shafie AA, Awaisu A. A Survey Exploring Knowledge and Perceptions of General Practitioners towards the Use Of Generic Medicines in the Northern State Of Malaysia.Health Policy 2010; 95: 229–235.
  205. Hassali MA, Awaisu A, Shafie AA, Saeed MS. Professional Training and Roles of Community Pharmacists in Malaysia: Views from General Medical Practitioners. Malaysian Family Physician 2009; 4(2&3).
  206. C.F. Neoh, Hassali MA, Shafie AA, Awaisu A, Tambayappa J. Compliance towards Dispensed Medication Labelling Standards: A Cross–Sectional Study In The State Of Penang, Malaysia. Current Drug Safety2009; 4(3):199–203.
  207. Hassali MA, Shafie AA, Awaisu A, Mohamed Ibrahim MI, Ahmed I. A Public Health Pharmacy Course at a Malaysian Pharmacy School. Am J Pharm Educ. 2009; 73 (7): Article 136.
  208. Hassan Y, Awaisu A, Abd Aziz N, Ismail O. The Complexity of Achieving Anticoagulation Control in the face of Warfarin – Phenytoin Interaction: An Asian Case Report. Pharm world Sci 2005; 27: 16–19.
  209. Awaisu A, Abd Aziz N, Hassan Y, Syed Sulaiman SA, Hassan J. Therapeutic Dilemma in the Management of Suspected leptospira Infection.EJHP–S 2005; 11(2): 46–50.
  210. Ping CC, Awaisu A, Hassan Y, Abd. Aziz N, Ghazali R.   Discontinuation of Penicillamine in the Absence of Alternative Orphan Drugs (Trientine–Zinc): A Case of Decompensated Liver Cirrhosis in Wilson’s Disease. Journal of Clinical Pharmacy and Therapeutics 2007; 32: 101 – 107.
  211. Yun LS, Hassan Y, Abd. Aziz N, Awaisu A, Ghazali R.A Comparison of Knowledge of Diabetes Mellitus between Patients with Diabetes and Healthy Adults: A Survey from North Malaysia. Patient Educ Couns 2007; 69: 47–54.
  212. Hassan Y, Awaisu A, Aziz NA, Aziz NHKA, Ismail O.Heparin–Induced Thrombocytopenia and recent advances in its therapy. Journal of Clinical Pharmacy and Therapeutics 2007; 32: 535–544.
  213. Awaisu A, Nik Mohamed MH, Al–Efan QAM. Perception of Pharmacy Students in Malaysia on the Use of Objective Structured Clinical Examinations to Evaluate Competence. Am J Pharm Educ. 2007; 71(6):Article 118.
  214. Awaisu A, Syed Sulaiman SA, Mohamed Ibrahim MI, Saad A. Antibiotics Utilization and Outcomes of Neonatal Sepsis among Patients Admitted to a University Teaching Hospital in Malaysia. Eastern J Med 2007; 12:6–14.
  215. Muhammad BY, Awaisu A. The Need for Enhancement of Research, Development, and    Commercialization of Natural Medicinal Products: Lessons from the Malaysian   Experience. Afr. J. Trad. CAM 2008; 5(2): 120–130.
  216. Awaisu A, Syed Sulaiman SA, Saad A. Emerging Infectious Diseases: An Assessment of Pharmacy Students’ Knowledge and Awareness of Avian Influenza A (H5N1) in Human and its Practice Implication in Malaysia. AJPCR 2008; 1(1): 49–56.
  217. Hassan Y, Awaisu A, Al–Meman AA, Abd Aziz N. The Pharmacotherapy of Heparin Induced Thrombocytopenia (HIT): A Review of Contemporary Therapeutic Challenges in Clinical Practice. Malaysian J Med Sci. 2008; 15(2): 3–13.
  218. Hassali MA, Shafie AA, Jamshed S, Mohamed Ibrahim MI, Awaisu A. Consumers’ Views on Generic Medicines: a Review of the Literature.IJPP 2009; 17: 79–88.
  219. Amir O, Hassan Y, Sarriff A, Awaisu A, Abd. Aziz N, Ismail O.Risk Factors Associated with Hyperkalemia Induced by ACEI–Drug Interactions among Cardiac Patients. PWS 2009; 31:387–393. doi: 10.1007/s11096–009–9288–x.
  220. Hassan Y, Mathialagan A, Awaisu A, Abd. Aziz N, Yahaya R, Salhani A. Trend in the Use of Oral Hypoglycemic Agents in an Outpatient Pharmacy Department of a Tertiary Hospital in Malaysia (2003–2006). AJCPR 2009; 2 (2): 40 – 46.